Caprock Group, Inc. Medpace Holdings, Inc. Transaction History

Caprock Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$132.02 - $168.26 $242,916 - $309,598	-1,840 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$109.38 - $149.19 $98,442 - $134,271	-900 Reduced 32.85%	1,840 $256,000
Q2 2020 Aug 05, 2020	SELL	$68.08 - $95.68 $74,888 - $105,248	-1,100 Reduced 28.65%	2,740 $255,000
Q1 2020 Apr 28, 2020	SELL	$61.71 - $101.95 $9,565 - $15,802	-155 Reduced 3.88%	3,840 $282,000
Q4 2019 Feb 04, 2020	SELL	$70.08 - $84.64 $4,204 - $5,078	-60 Reduced 1.48%	3,995 $336,000

Q1 2019 Apr 12, 2019	SELL	$49.38 - $70.58 $49,380 - $70,580	-1,000 Reduced 19.78%	4,055 $239,000
Q3 2018 Oct 17, 2018	SELL	$43.25 - $63.74 $5,406 - $7,967	-125 Reduced 2.41%	5,055 $303,000
Q2 2018 Jul 23, 2018	BUY	$34.03 - $45.46 $176,275 - $235,482	5,180 New	5,180 $223,000

622

25.1M

154K

117K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.6B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Caprock Group, Inc. with notifications on news.